November 17, 2017 /

Wave Life Sciences (November 2017)

by: Parent Project Muscular Dystrophy

Wave Life Sciences (November 2017)

PPMD and Wave Life Sciences hosted a webinar on November 14, 2017 to provide an overview of Wave’s stereopure exon skipping oligonucleotide programs for the treatment of Duchenne muscular dystrophy and an introduction to the planned Phase 1 clinical trial.

Research & Clinical Trial Webinars, Webinars

Posted on November 17, 2017

You may also like

Understanding the Potential of Epicatechin (December 2015)

Understanding the Potential of Epicatechin (December 2015)

Posted on December 16, 2015

Research & Clinical Trial Webinars, Webinars

Understanding Myostatin Inhibition (November 2015)

Understanding Myostatin Inhibition (November 2015)

Posted on November 13, 2015

Research & Clinical Trial Webinars, Webinars

Decode Duchenne Genetic Testing Program (November 2015)

Decode Duchenne Genetic Testing Program (November 2015)

Posted on November 5, 2015

Care Webinars, Webinars

PF-06252616 (Anti-Myostatin) Webinar (June 2015)

PF-06252616 (Anti-Myostatin) Webinar (June 2015)

Posted on June 24, 2015

Research & Clinical Trial Webinars, Webinars

Caregiver Webinar (June 2015)

Caregiver Webinar (June 2015)

Posted on June 15, 2015

Care Webinars, Webinars

CAT-1004 (Catabasis) Clinical Trial Webinar (May 2015)

CAT-1004 (Catabasis) Clinical Trial Webinar (May 2015)

Posted on May 29, 2015

Research & Clinical Trial Webinars, Webinars

FOR-DMD Study Webinar (April 2015)

FOR-DMD Study Webinar (April 2015)

Posted on April 17, 2015

Research & Clinical Trial Webinars, Webinars

Orthopedic Complications in Duchenne (March 2015)

Orthopedic Complications in Duchenne (March 2015)

Posted on April 3, 2015

Care Webinars, Webinars

«1…18 192021 22…24 »

Page 20 of 24

Join Our Mailing List